Clinical Trial Update: A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the effect of Bimekizumab on gene expression biomarkers in adults with moderate to severe plaque psoriasis, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Phase 3 | Status: RECRUITING